IN-VITRO EFFICACY OF PIPERACILLIN/SULBACTAM AGAINST MULTIDRUG-RESISTANT PSEUDOMONAS AERUGINOSA: A COMPARATIVE STUDY WITH PIPERACILLIN/TAZOBACTAM AND CEFOPERAZONE/SULBACTAM. FMHR. 2026;4(3):4971-4977. Accessed November 8, 2026. https://fmhr.net/index.php/fmhr/article/view/3904